Bharat Immunologicals Net Income vs. Debt to Equity

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Drivers Module shows relationships between Bharat Immunologicals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Bharat Immunologicals Biologicals Corp Ltd over time as well as its relative position and ranking within its peers. Check also Trending Equities

Bharat Immunologicals Debt to Equity vs. Net Income Fundamental Analysis

Bharat Immunologicals Biologicals Corp Ltd is rated below average in net income category among related companies. It is rated fourth in debt to equity category among related companies . The ratio of Net Income to Debt to Equity for Bharat Immunologicals Biologicals Corp Ltd is about  744,737 
Net income is the profit of a company for the reporting period which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most watched numbers by money managers as well as individual investors.
Bharat Immunologicals 
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
=
2.83 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin which measures income as a percentage of sales.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Bharat Immunologicals 
D/E 
 = 
Total Debt 
Total Equity 
=
3.80 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging barrowing against the capital invested by the owners.

Bharat Immunologicals Debt to Equity Comparison

Bharat Immunologicals is currently under evaluation in debt to equity category among related companies.